4//SEC Filing
Chadwick Jeremy G 4
Accession 0000950170-24-025097
CIK 0001815442other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:16 PM ET
Size
7.2 KB
Accession
0000950170-24-025097
Insider Transaction Report
Form 4
Chadwick Jeremy G
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+80,548→ 80,548 totalExercise: $43.50Exp: 2034-02-28→ Common Stock (80,548 underlying) - Award
Common Stock
2024-03-01+13,425→ 46,758 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in three equal annual installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date.
- [F2]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2024, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001388406
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:16 PM ET
- Size
- 7.2 KB